Trial intelligence / Profile preview

Eye Shape Changes in Young Adults With Myopia Treated With Atropine or Multifocal Contacts

NCT06450132Phase 4Active, not recruiting

Sponsor
The Ohio State University
Start
Aug 2024
Primary completion
Jun 2026
Modality
Small Molecules, Drug Delivery Systems
Countries
1
01

Overview

A Phase 4 trial of NVK002 in myopia, sponsored by The Ohio State University. Started Aug 2024; status: active, not recruiting.

02

Drugs

NVK002
03

Conditions

myopia

Beyond the preview

Go deeper on NCT06450132.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06450132.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call